Loading…
Association of FGF‐19 and FGF‐21 levels with primary sarcopenia
Aim Serum fibroblast growth factor (FGF)‐19 and FGF‐21 levels have been reported to be associated with muscle hemostasis. This study aims to explore the relationship between the levels of these markers and sarcopenia. Methods In our single‐center, cross‐sectional study, patients over 65 years old pr...
Saved in:
Published in: | Geriatrics & gerontology international 2021-10, Vol.21 (10), p.959-962 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aim
Serum fibroblast growth factor (FGF)‐19 and FGF‐21 levels have been reported to be associated with muscle hemostasis. This study aims to explore the relationship between the levels of these markers and sarcopenia.
Methods
In our single‐center, cross‐sectional study, patients over 65 years old presenting to the geriatric outpatient clinic were included. Patients with secondary sarcopenia were excluded. The Strength–Assistance with walking–Rising from a chair–Climbing stairs and Falls (SARC‐F) questionnaire was applied to all patients. Sarcopenia was determined by handgrip strength (HGS), bioelectrical impedance analysis and 6‐m walk test. Serum samples were stored at −80°C until measurement. The ELISA method was used to assess FGF‐19 and FGF‐21 levels.
Results
In total, 88 patients (54 women) were included. There were 43 patients in the sarcopenia group and 45 patients without sarcopenia in the control group. In those with sarcopenia, FGF‐19 was lower (P = 0.04) and FGF‐21 was higher (P = 0.021). There was a direct correlation between FGF‐19 with SARC‐F and HGS (P = 0.04, B = 0.178, P = 0.006, B = 0.447) while FGF‐21 was inversely correlated with HGS and positively correlated with 6‐m walking time (P = 0.016, B = −0.428, P = 0.004, B = 0.506).
Conclusions
Our results reveal that low FGF‐19 and high FGF‐21 may be associated with sarcopenia and this finding could be explained by the impacted muscle strength. Geriatr Gerontol Int 2021; 21: 959–962. |
---|---|
ISSN: | 1444-1586 1447-0594 |
DOI: | 10.1111/ggi.14263 |